Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
KPRXCompany Name
KIORA PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQKIORA PHARMACEUTICALS INC - Capital Expenditures Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
KPRX - CapEx % Historical data
| Date | Capital Expenditure | Capital Expenditures Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -12.84K | 0% | $ 0 |
| 3/31/2025 | $ -45.03K | 0% | $ 20K |
| 12/31/2024 | $ 6.26K | 0.04% | $ 16.02M |
| 9/30/2024 | $ 0 | 0% | $ 16.02M |
| 6/30/2024 | $ 0 | 0% | $ 16.02M |
| 3/31/2024 | $ 0 | 0% | $ 16M |
| 12/31/2023 | $ 0 | 0% | $ 0 |
| 9/30/2023 | $ 0 | 0% | $ 0 |
| 6/30/2023 | $ 0 | 0% | $ 0 |
| 3/31/2023 | $ 0 | 0% | $ 0 |
Key Performance Insights, Last 5 Years
- KIORA PHARMACEUTICALS INC's latest trailing twelve months (TTM) CapEx % stands at 0%.
- Over the past 5 years, KIORA PHARMACEUTICALS INC's average CapEx % has been 341.54%.
- The median CapEx % for KIORA PHARMACEUTICALS INC during this period was 481.96%
- KIORA PHARMACEUTICALS INC reached its highest CapEx % over the past 5 years at 529.6%.
- The lowest CapEx % recorded by KIORA PHARMACEUTICALS INC in the same timeframe 0.04%
Similar metrics to Revenues:
- Capital Expenditures to Operating Cash Flow - [Calculation] The CapEx to Operating Cash Flow ratio, measures how much of a company’s operating cash flow is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by net operating cash flow [NCFO].
- Capital Expenditure - [Cash Flow Statement] CapEX, also know as capital expenditures, is a component of investing cash flow [NCFI] that refers to funds that are used to acquire, improve or maintain long-term assets [AssestsNC] of the company. Capital expense may include the purchase of new equipment, machinery, buildings or warehouses, furniture, software or intangibles such as intellectual property.
- Capital Expenditures Coverage - [Calculation] The Capital Expenditure Ratio, or capex coverage, describes the ability of a business to generate enough cash from day-to-day operations to cover capital expenditures. It is calculated by dividing the cash flow from operations [NCFO] by its capital expenditures [CapEx].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
- Cost of Revenue Margin - [Calculation] The Cost of Revenue [CoR] expressed as a percentage of [Revenue]. Also named Cost Revenue Ratio.
Definition of Capital Expenditures Margin
[Calculation] The CapEx Margin, also named Capex to Revenue Ratio, measures how much of a company’s revenue is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by [Revenue].CapEx / Revenues
(=) CapEx % CapEx % for KIORA PHARMACEUTICALS INC is calculated as follows: CapEx [ $ 0 ] / Revenues [ $ 0 ]
(=) CapEx % [ 0% ] KPRX - Capital Expenditures Margin, Last 5 years
0.04%
Minimum
Dec 31, 2024
529.6%
Maximum
Jun 30, 2021
341.54%
Average
481.96%
Median
CapEx % Benchmark AnalysisMarket
The chart above depicts the distribution of CapEx % for companies in the Total Stock Market. The average CapEx % of the companies is 3.47% with a standard deviation of 3.27%.
The following table provides additional summary stats:
CapEx % in the Market:
| filtered constituents | 2.85K |
|---|---|
| min | 0% |
| max | 15.02% |
| average | 3.47% |
| median | 2.43% |
| std | 3.27% |